European approval for Velphoro

The European Commission approved Velphoro sucroferric oxyhydroxide from Vifor-Fresenius Medical Care Renal Pharma Ltd. to control serum phosphorus levels in adults with chronic kidney disease (CKD) on hemodialysis or peritoneal dialysis. The oral iron-based phosphate binder is marketed for the indication in the U.S. ...